Published: 2:56pm, 2 Jan, 2019 Updated: 4:41pm, 2 Jan, 2019
Small, generic drug manufacturers in China are facing an end to juicy profit margins after the government launched a pilot scheme in which major cities will buy certain medications in bulk. The move will force companies to bid for contracts and has already reduced prices by an average of 52%, while one treatment cost fell by 90%. In China, there is no shortage of cheap generics.